PUBLISHER: The Business Research Company | PRODUCT CODE: 1942578
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942578
A coagulation analyzer is a medical device designed to swiftly and efficiently measure blood platelet levels. Its primary function involves assessing the blood's clotting ability, enabling the identification and evaluation of bleeding disorders such as hemophilia. Additionally, it aids in monitoring patients who are prescribed anticoagulant medications such as aspirin, heparin, or warfarin.
The principal product categories of coagulation analyzers comprise semi-automated coagulation analyzers, automated coagulation analyzers, manual analyzers, and other specialized variants. Semi-automated coagulation analyzers serve as essential medical diagnostic tools for assessing various components present in human blood. These analyzers facilitate multiple test types, including prothrombin time testing, fibrinogen testing, activated partial thromboplastin time testing, d-dimer testing, platelet function testing, anti-factor Xa testing, among others. These tests utilize diverse technologies such as optical, mechanical, electrochemical, and other advanced methodologies. Coagulation analyzers cater to a range of end-users, including hospitals, clinics, diagnostic centers, and other medical facilities where the accurate assessment of blood coagulation is crucial for diagnosis and treatment purposes.
Tariffs are influencing the coagulation analyzer market by increasing costs of imported optical sensors, reagents, microfluidic components, and electronic control systems used in automated analyzers. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher costs for analyzer exports. These tariffs are raising procurement expenses and slowing replacement cycles. However, they are also encouraging local analyzer assembly, domestic reagent production, and long-term supply chain localization.
The coagulation analyzer market research report is one of a series of new reports from The Business Research Company that provides coagulation analyzer market statistics, including coagulation analyzer industry global market size, regional shares, competitors with a coagulation analyzer market share, detailed coagulation analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation analyzer industry. This coagulation analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The coagulation analyzer market size has grown strongly in recent years. It will grow from $3.26 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular disorders, growth in anticoagulant therapy monitoring, expansion of hospital diagnostic infrastructure, adoption of standardized coagulation testing protocols, rising surgical procedure volumes.
The coagulation analyzer market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing demand for rapid coagulation diagnostics, expansion of decentralized testing environments, rising investments in advanced hematology analyzers, growing focus on patient safety monitoring, integration of smart diagnostics platforms. Major trends in the forecast period include increasing adoption of fully automated coagulation systems, rising demand for high-sensitivity clotting assays, growing integration of ai-assisted result interpretation, expansion of point-of-care coagulation testing, enhanced focus on workflow automation.
The rising incidence of cardiac diseases is expected to drive the growth of the coagulation analyzer market in the coming years. Cardiac diseases include a variety of conditions that affect both the heart and blood vessels. Coagulation analyzers are utilized in the management of cardiac diseases by assessing blood clotting parameters, guiding anticoagulant therapy, and preventing complications, thereby contributing to effective treatment and care. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 year. Therefore, the rising incidence of cardiac diseases is driving the growth of the coagulation analyzer market.
Major companies in the coagulation analyzer market are developing technologically advanced products, such as fully automated coagulation analyzers, to manage high test volumes with minimal human intervention. A fully automated coagulation analyzer is a laboratory device that performs automated testing of blood clotting processes, enabling accurate and efficient diagnosis of coagulation disorders without the need for manual input. For example, in March 2024, Zybio Inc., a China-based provider of in vitro diagnostic reagents and equipment, launched the EXT 9800 fully automated coagulation analyzer. The EXT 9800 is notable for being the first to employ micro magnetic particle detection, allowing for visualized, multi-dimensional analysis of the coagulation process, which enhances accuracy and depth. It redefines automated detection with a distributed structure, modular expandability, and high-throughput capabilities, offering a lightweight, comprehensive solution for laboratories. Additionally, the analyzer features a complete upgrade across the entire testing process, establishing a new standard for innovation in coagulation testing.
In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a medical device company based in China, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition will enable Mindray to accelerate the development of its overseas supply chain platform, access a skilled international team, and enhance its in-vitro diagnostics portfolio. Mindray is committed to providing resources and support to DiaSys while leveraging its extensive experience in global integration to promote effective synergistic growth for both companies. DiaSys Diagnostic Systems GmbH is a manufacturer of coagulation analyzers based in Germany.
Major companies operating in the coagulation analyzer market are Siemens AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Werfen S.A., Nihon Kohden Corporation, Diagnostica Stago SAS, ARKRAY Inc., Beckman Coulter Inc., Helena Laboratories Corporation, Maccura Biotechnology Co. Ltd., Beijing Succeeder Technology Inc., Trivitron Healthcare Pvt. Ltd., A&T Corporation, ACON Laboratories Inc., Genrui Biotech Inc., Teco Medical Instruments, Eurolyser Diagnostica GmbH, Meril Life Science Pvt. Ltd., Bioevopeak Co. Ltd.
North America was the largest region in the coagulation analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coagulation analyzer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the coagulation analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The coagulation analyzer market consists of sales of hematology coagulation analyzers, standalone coagulation analyzers, and portable analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Coagulation Analyzer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses coagulation analyzer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for coagulation analyzer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coagulation analyzer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.